🔁 Friday Rewind with Xtalks Markets, drug modalities, infrastructure and breakthrough therapies, browse the headlines that shaped the life sciences conversation this week. 💹 Pharma & Biotech IPOs: What’s Driving 2025 Market Buzz? Catch the market pulse: https://buff.ly/j2VvQnS 🗳️ Poll: Which Drug Modality Has the Most Untapped Potential? Weigh in here: https://buff.ly/ebunQoe ⭐ Esaote’s FDA-Cleared Portable Ultrasound Systems Expands Imaging Options See the new device: https://buff.ly/l3BcHj1
🔁 Friday Rewind with Xtalks Markets, drug modalities, infrastructure an…
1 views3 months ago
FacebookXtalks Webinars
Learn how to launch your first-in-human (FIH) radiopharmaceutical therapy (RLT) clinical trial successfully with Jenny Keppler, MBA in this specialized webinar hosted by TD2 Oncology. She will break down the essential infrastructure, strategic planning, and logistics required to successfully navigate complex challenges like isotope availability, site radiation compliance, and global regulatory considerations. Register now to gain practical guidance on moving your RLT candidate from IND submissio
0:38
Learn how to launch your first-in-human (FIH) radiopharmaceutical …
4 views2 weeks ago
FacebookXtalks Webinars
🔁 Friday Rewind with Xtalks From GLP-1 price deals to pediatric approvals, TV ad narratives and a high-stakes legal clash, here’s your week at a glance. 💵 Lilly & Novo Lock In Obesity Drug Pricing Deals with Trump Administration See what’s changing: https://buff.ly/OBAAlKS 🫀 High-Sensitivity Troponin Assay Cleared for Earlier Heart Attack Detection Dig into the data: https://buff.ly/tblNPbU 🧒 Linzess Becomes First IBS-C Option for Kids Over 7 Years old Check the new indication: https://buff.
🔁 Friday Rewind with Xtalks From GLP-1 price deals to pediatric app…
5 views1 month ago
FacebookXtalks Webinars
In this episode, Dr. Craig Erickson, Chief Medical Advisor at Spinogenix, Inc., discusses pioneering therapies for fragile X, ALS and more, and the future of personalized neurodevelopmental care. Listen now at https://buff.ly/52S7pK9 🎙️ | Xtalks Webinars
In this episode, Dr. Craig Erickson, Chief Medical Advisor at Spinogen…
7 views4 months ago
FacebookXtalks Webinars
 ️ ICYMI: Tune in to the latest episode of the Xtalks Life Science...
0:42
 ️ ICYMI: Tune in to the latest episode of the Xtalks Life Science...
1.2K views2 weeks ago
FacebookXtalks Webinars
In this episode, hear about Intensity Therapeutics’ innovative intratumoral therapeutics, currently in trials for soft tissue sarcoma and breast cancer, from company founder, chairman and CEO Lewis Bender. Listen now at https://buff.ly/3Zxe7kd 🎙️ | Xtalks Webinars
0:48
In this episode, hear about Intensity Therapeutics’ innovative intratum…
11 viewsDec 13, 2024
FacebookXtalks Webinars
💡 🎙️ Tune in to the latest episode of the Xtalks Life Science Podcast featuring an enlightening conversation with Dr. Travaglia and Dr. Sethi as they delve into groundbreaking advancements in #ALS research and advocacy. Last month, the #FNIH launched the AMP #ALSresearch program to accelerate the discovery and development of treatments and diagnostics for ALS. This initiative aims to identify biomarkers and clinical outcome assessments for earlier diagnosis and faster drug development. 🎧 Watc
0:40
💡 🎙️ Tune in to the latest episode of the Xtalks Life Science Podcast fe…
3 viewsJul 2, 2024
FacebookXtalks Webinars
0:30
The WHO has proposed a 21% budget cut following the US gover…
1 views8 months ago
FacebookXtalks Webinars
0:37
✨ 🖤 Rap Snacks, the "Official Snack Brand of Hip Hop," is making wav…
1.1K viewsMar 8, 2024
FacebookXtalks Webinars
Join our poll to explore how proposed US pharmaceutical imp…
2 views7 months ago
FacebookXtalks Webinars
0:47
💡 How is AI reshaping the future of medical writing? In this Xtalks Sp…
10 viewsDec 19, 2024
FacebookXtalks Webinars
0:30
The FDA approved Mirum’s Ctexli (chenodiol) for cerebrotendinous …
1.2K views2 weeks ago
FacebookXtalks Webinars
In this episode, Ayesha chats with Dr. Sumita Bhatta, VP and Global …
7 views7 months ago
FacebookXtalks Webinars
0:31
Metsera’s IPO introduces a novel class of therapies to the obesity la…
10 views10 months ago
FacebookXtalks Webinars
0:38
 Xtalks Spotlight: In our latest interview, Matt Brown, CEO of...
1.2K views3 weeks ago
FacebookXtalks Webinars
0:49
🌟💬 Xtalks Spotlight: Ensuring compliance and maintaining high-…
21 viewsJul 16, 2024
FacebookXtalks Webinars
0:30
Belgian AgeTech company Nobi has secured $37 million in an oversub…
1.2K views3 weeks ago
FacebookXtalks Webinars
0:30
The FDA just expanded unannounced inspections to forei…
1.2K views3 weeks ago
FacebookXtalks Webinars
0:38
Multivalent mRNA vaccines hold immense promise, but traditional …
1.2K views3 weeks ago
FacebookXtalks Webinars
0:30
Soleno Therapeutics’ Vykat XR received FDA approval for hyperp…
24 views3 weeks ago
FacebookXtalks Webinars
0:30
Valneva’s chikungunya vaccine, IXCHIQ, shows strong Phase III re…
10 views11 months ago
FacebookXtalks Webinars
0:16
Be a part of our life science community to get access to all fre…
27.3K viewsOct 23, 2019
FacebookXtalks Webinars
MASH, also known as fatty liver disease, is projected to impact ov…
13 views3 months ago
FacebookXtalks Webinars
0:41
The Rett syndrome community received great news this year. Th…
1.2K views3 weeks ago
FacebookXtalks Webinars
0:30
International Childhood Cancer Day 2025 is about driving real change. …
1.2K views3 weeks ago
FacebookXtalks Webinars
Beta Bionics has successfully raised $234.6 million from its IPO, …
2 views10 months ago
FacebookXtalks Webinars
Potency assays are critical to ensuring consistent, safe and effe…
1.2K views2 weeks ago
FacebookXtalks Webinars
0:32
❓ How can high-concentration formulations and advanced injecti…
2 views5 months ago
FacebookXtalks Webinars
0:55
In this episode of the Xtalks Food Podcast, the team learns about tit…
10 viewsApr 6, 2023
FacebookXtalks Webinars
0:40
 Xtalks Spotlight: As clinical trials become more complex,...
1.2K viewsAug 1, 2024
FacebookXtalks Webinars
See more videos
Static thumbnail place holder